Inhibition of the transcription factor c-Jun by the MAPK family, and not the NF-κB pathway, suggests that peanut extract has anti-inflammatory properties

Molecular Immunology

Volumn 52, Issue 3-4, 2012, Pages 125-132

  Catalán, Úrsula ^a   Fernández Castillejo, Sara ^a   Anglès, Neus ^b   Morelló, Jose Ramón ^b   Yebras, Martí ^a   Solà, Rosa ^a  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^b La Morella Nuts SA   (Spain)

Author keywords

Lipopolysaccharide; NF B; THP 1; Tumor necrosis factor ; Tumor necrosis factor converting enzyme

Indexed keywords

FLAVONOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTATE DEHYDROGENASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; PEANUT EXTRACT; POLYPHENOL; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ASSAY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG CYTOTOXICITY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; EXTRACELLULAR MATRIX; FLUOROMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INCUBATION TIME; INFANT; MALE; MONOCYTE; PRIORITY JOURNAL;

ADAM PROTEINS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIS HYPOGAEA; CELL LINE; CELL LINE, TUMOR; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; L-LACTATE DEHYDROGENASE; LIPOPOLYSACCHARIDES; MONOCYTES; NF-KAPPA B; PLANT EXTRACTS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

ARACHIS HYPOGAEA;

EID: 84861739010     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2012.05.007     Document Type: Article

References (43)

1. Gerszten R.E., Asnani A., Carr S.A. Status and prospects for discovery and verification of new biomarkers of cardiovascular disease by proteomics. Circulation Research 2011, 109:463-474.
2. Ross R. Atherosclerosis - an inflammatory disease. New England Journal of Medicine 1999, 340:115-126.
3. Katsume A., Okigaki M., Matsui A., Che J., Adachi Y., Kishita E., et al. Early inflammatory reactions in atherosclerosis are induced by proline-rich tyrosine kinase/reactive oxygen species-mediated release of tumor necrosis factor-alpha and subsequent activation of the p21Cip1/Ets-1/p300 system. Arteriosclerosis, Thrombosis, and Vascular Biology 2011, 31:1084-1092.
4. Devaraj S., Harris A., Jialal I. Modulation of monocyte-macrophage function with alpha-tocopherol: implications for atherosclerosis. Nutrition Reviews 2002, 60:8-14.
5. Gee K., Lim W., Ma W., Nandan D., Diaz-Mitoma F., Kozlowski M., et al. Differential regulation of CD44 expression by lipopolysaccharide (LPS) and TNF-alpha in human monocytic cells: distinct involvement of c-Jun N-terminal kinase in LPS-induced CD44 expression. Journal of Immunology 2002, 169:5660-5672.
6. Guha M., Mackman N. LPS induction of gene expression in human monocytes. Cellular Signalling 2001, 13:85-94.
7. Barnes P.J., Karin M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. New England Journal of Medicine 1997, 336:1066-1071.
8. Black R.A. Tumor necrosis factor-alpha converting enzyme. International Journal of Biochemistry and Cell Biology 2002, 34:1-5.
9. Ishisaka R., Sato N., Tanaka K., Takeshige T., Iwata H., Klostergaard J., et al. A part of the transmembrane domain of pro-TNF can function as a cleavable signal sequence that generates a biologically active secretory form of TNF. Journal of Biochemistry 1999, 126:413-420.
10. Horiuchi T., Mitoma H., Harashima S., Tsukamoto H., Shimoda T. Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents. Rheumatology 2010, 49:1215-1228.
11. Katakowski M., Chen J., Zhang Z.G., Santra M., Wang Y., Chopp M. Stroke-induced subventricular zone proliferation is promoted by tumor necrosis factor-alpha-converting enzyme protease activity. Journal of Cerebral Blood Flow and Metabolism 2007, 27:669-678.
12. Zheng X., Jiang F., Katakowski M., Kalkanis S.N., Hong X., Zhang X., et al. Inhibition of ADAM17 reduces hypoxia-induced brain tumor cell invasiveness. Cancer Science 2007, 98:674-684.
13. Tang P., Hung M.C., Klostergaard J. Human pro-tumor necrosis factor is a homotrimer. Biochemistry 1996, 35:8216-8225.
14. Black R.A., Rauch C.T., Kozlosky C.J., Peschon J.J., Slack J.L., Wolfson M.F., et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 1997, 385:729-733.
15. Chou Y.C., Sheu J.R., Chung C.L., Hsiao C.J., Hsueh P.J., Hsiao G. Hypertonicity-enhanced TNF-alpha release from activated human monocytic THP-1 cells requires ERK activation. Biochimica et Biophysica Acta 2011, 1810:475-484.
16. Ramana K.V. Tumor necrosis factor-alpha converting enzyme: implications for ocular inflammatory diseases. International Journal of Biochemistry and Cell Biology 2010, 42:1076-1079.
17. Beutler B. Tlr4: central component of the sole mammalian LPS sensor. Current Opinion in Immunology 2000, 12:20-26.
18. Witkamp R., Monshouwer M. Signal transduction in inflammatory processes, current and future therapeutic targets: a mini review. Veterinary Quarterly 2000, 22:11-16.
19. Dayer J.M., Molnarfi N., Burger D. From cellular receptors to transduction-transcription pathways for cytokines: at which level should the inhibition be targeted in inflammation?. Expert Opinion on Biological Therapy 2005, 5(Suppl. 1):S83-S96.
20. Subramaniam D., Ramalingam S., Linehan D.C., Dieckgraefe B.K., Postier R.G., Houchen C.W., et al. RNA binding protein CUGBP2/CELF2 mediates curcumin-induced mitotic catastrophe of pancreatic cancer cells. PLoS One 2011, 6:e16958.
21. Cheneval D., Kastelic T., Fuerst P., Parker C.N. A review of methods to monitor the modulation of mRNA stability: a novel approach to drug discovery and therapeutic intervention. Journal of Biomolecular Screening 2010, 15:609-622.
22. Walsh C.T., Garneau-Tsodikova S., Gatto G.J. Protein posttranslational modifications: the chemistry of proteome diversifications. Angewandte Chemie International Edition (in English) 2005, 44:7342-7372.
23. Singh U., Tabibian J., Venugopal S.K., Devaraj S., Jialal I. Development of an in vitro screening assay to test the antiinflammatory properties of dietary supplements and pharmacologic agents. Clinical Chemistry 2005, 51:2252-2256.
24. Essafi-Benkhadir K., Refai A., Riahi I., Fattouch S., Karoui H., Quince Essafi M. (Cydonia oblonga Miller) peel polyphenols modulate LPS-induced inflammation in human THP-1-derived macrophages through NF-κB, p38MAPK and Akt inhibition. Biochemical and Biophysical Research Communications 2012.
25. Calixto J.B., Otuki M.F., Santos A.R. Anti-inflammatory compounds of plant origin. Part I. Action on arachidonic acid pathway, nitric oxide and nuclear factor κB (NF-κB). Planta Medica 2003, 69:973-983.
26. Kris-Etherton P.M., Hecker K.D., Bonanome A., Coval S.M., Binkoski A.E., Hilpert K.F., et al. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. American Journal of Medicine 2002, 113(Suppl. 9B):71S-88S.
27. Ortega R.M. Importance of functional foods in the Mediterranean diet. Public Health Nutrition 2006, 9:1136-1140.
28. Schulz V.J., Smit J.J., Willemsen K.J., Fiechter D., Hassing I., Bleumink R., et al. Activation of the aryl hydrocarbon receptor suppresses sensitization in a mouse peanut allergy model. Toxicological Sciences 2011.
29. Moverare R., Ahlstedt S., Bengtsson U., Borres M.P., van Hage M., Poorafshar M., et al. Evaluation of IgE antibodies to recombinant peanut allergens in patients with reported reactions to peanut. International Archives of Allergy and Immunology 2011, 156:282-290.
30. Chen X., Zhuang Y., Wang Q., Moutsoglou D., Ruiz G., Yen S.E., et al. Analysis of the effector activity of Ara h 2 and Ara h 6 by selective depletion from a crude peanut extract. Journal of Immunological Methods 2011.
31. Ortega N., Romero M.P., Macia A., Reguant J., Angles N., Morello J.R., et al. Obtention and characterization of phenolic extracts from different cocoa sources. Journal of Agricultural and Food Chemistry 2008, 56:9621-9627.
32. Monagas M., Garrido I., Lebron-Aguilar R., Bartolome B., Gomez-Cordoves C. Almond (Prunus dulcis (Mill.) D.A. Webb) skins as a potential source of bioactive polyphenols. Journal of Agricultural and Food Chemistry 2007, 55:8498-8507.
33. Magness S.T., Jijon H., Van Houten Fisher N., Sharpless N.E., Brenner D.A., Jobin C. In vivo pattern of lipopolysaccharide and anti-CD3-induced NF-κ B activation using a novel gene-targeted enhanced GFP reporter gene mouse. Journal of Immunology 2004, 173:1561-1570.
34. Koba M., Konopa J. Actinomycin D and its mechanisms of action. Postepy Higieny i Medycyny Doswiadczalnej 2005, 59:290-298. (Online).
35. Jang C.H., Choi J.H., Byun M.S., Jue D.M. Chloroquine inhibits production of TNF-alpha, IL-1beta and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes. Rheumatology 2006, 45:703-710.
36. Hu J.H., Zhu X.Z. Rotenone-induced neurotoxicity of THP-1 cells requires production of reactive oxygen species and activation of phosphatidylinositol 3-kinase. Brain Research 2007, 1153:12-19.
37. Oda T., Hirota K., Nishi K., Takabuchi S., Oda S., Yamada H., et al. Activation of hypoxia-inducible factor 1 during macrophage differentiation. American Journal of Physiology: Cell Physiology 2006, 291:C104-C113.
38. Lee H.S., Kim S.D., Lee W.M., Endale M., Kamruzzaman S.M., Oh W.J., et al. A noble function of BAY 11-7082: inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations. European Journal of Pharmacology 2010, 627:85-91.
39. Doedens J.R., Black R.A. Stimulation-induced down-regulation of tumor necrosis factor-alpha converting enzyme. Journal of Biological Chemistry 2000, 275:14598-14607.
40. Rozenova K.A., Deevska G.M., Karakashian A.A., Nikolova-Karakashian M.N. Studies on the role of acid sphingomyelinase and ceramide in the regulation of tumor necrosis factor alpha (TNFalpha)-converting enzyme activity and TNFalpha secretion in macrophages. Journal of Biological Chemistry 2010, 285:21103-21113.
41. Ermert M., Pantazis C., Duncker H.R., Grimminger F., Seeger W., Ermert L. In situ localization of TNFalpha/beta, TACE and TNF receptors TNF-R1 and TNF-R2 in control and LPS-treated lung tissue. Cytokine 2003, 22:89-100.
42. Armstrong L., Godinho S.I., Uppington K.M., Whittington H.A., Millar A.B. Contribution of TNF-alpha converting enzyme and proteinase-3 to TNF-alpha processing in human alveolar macrophages. American Journal of Respiratory Cell and Molecular Biology 2006, 34:219-225.
43. Doedens J.R., Mahimkar R.M., Black R.A. TACE/ADAM-17 enzymatic activity is increased in response to cellular stimulation. Biochemical and Biophysical Research Communications 2003, 308:331-338.